1. Zinc drives vasorelaxation by acting in sensory nerves, endothelium and smooth muscle.
- Author
-
Betrie AH, Brock JA, Harraz OF, Bush AI, He GW, Nelson MT, Angus JA, Wright CE, and Ayton S
- Subjects
- Aged, Animals, Blood Pressure drug effects, Blood Pressure physiology, Calcitonin Gene-Related Peptide metabolism, Calcium Channels, N-Type metabolism, Chelating Agents pharmacology, Cytoplasm metabolism, Endothelium, Vascular drug effects, Endothelium, Vascular innervation, Ethylenediamines pharmacology, Female, HEK293 Cells, Humans, Male, Mice, Mice, Knockout, Middle Aged, Muscle, Smooth, Vascular drug effects, Patch-Clamp Techniques, Prostaglandin-Endoperoxide Synthases metabolism, Prostaglandins metabolism, Rats, TRPA1 Cation Channel genetics, TRPA1 Cation Channel metabolism, Vasodilation drug effects, Endothelium, Vascular metabolism, Muscle, Smooth, Vascular physiology, Sensory Receptor Cells metabolism, Vasodilation physiology, Zinc metabolism
- Abstract
Zinc, an abundant transition metal, serves as a signalling molecule in several biological systems. Zinc transporters are genetically associated with cardiovascular diseases but the function of zinc in vascular tone regulation is unknown. We found that elevating cytoplasmic zinc using ionophores relaxed rat and human isolated blood vessels and caused hyperpolarization of smooth muscle membrane. Furthermore, zinc ionophores lowered blood pressure in anaesthetized rats and increased blood flow without affecting heart rate. Conversely, intracellular zinc chelation induced contraction of selected vessels from rats and humans and depolarized vascular smooth muscle membrane potential. We demonstrate three mechanisms for zinc-induced vasorelaxation: (1) activation of transient receptor potential ankyrin 1 to increase calcitonin gene-related peptide signalling from perivascular sensory nerves; (2) enhancement of cyclooxygenase-sensitive vasodilatory prostanoid signalling in the endothelium; and (3) inhibition of voltage-gated calcium channels in the smooth muscle. These data introduce zinc as a new target for vascular therapeutics.
- Published
- 2021
- Full Text
- View/download PDF